Implication of von Willebrand Factor as a Regulator of Tumor Cell Metastasis: Potential Perioperative Use of Desmopressin and Novel Peptide Analogs | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

Implication of von Willebrand Factor as a Regulator of Tumor Cell Metastasis: Potential Perioperative Use of Desmopressin and Novel Peptide Analogs

Acta Haematol (2013) 129 (4): 223–224.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Addition of vasopressin synthetic analogue [V4Q5]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models

Juan Garona
Marina Pifano
Maria B. Pastrian
Daniel E. Gomez
Giselle V. Ripoll
Daniel F. Alonso

Clinical & Experimental Metastasis (2016) 33 (6): 589.

A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients

Ruth S Weinberg
Marcelo O Grecco
Gimena S Ferro
Debora J Seigelshifer
Nancy V Perroni
Francisco J Terrier
Analía Sánchez-Luceros
Esteban Maronna
Ricardo Sánchez-Marull
Isabel Frahm
Marcelo D Guthmann
Daniela Di Leo
Eduardo Spitzer
Graciela N Ciccia
Juan Garona
Marina Pifano
Ana V Torbidoni
Daniel E Gomez
Giselle V Ripoll
Roberto E Gomez
Ignacio A Demarco
Daniel F Alonso

SpringerPlus (2015) 4 (1)

Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial growth factor and related to disease severity

Xia Yang
Hai-jian Sun
Zhi-rong Li
Hao Zhang
Wei-jun Yang
Bing Ni
Yu-zhang Wu

BMC Cancer (2015) 15 (1)